What does research say about using beta (beta blockers) blockers for anxiety?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta-Blockers for Anxiety: Evidence-Based Recommendations

Beta-blockers, particularly propranolol, are effective for situational performance anxiety (stage fright) but are NOT recommended as first-line treatment for chronic anxiety disorders like generalized anxiety disorder, panic disorder, or social anxiety disorder. 1, 2

Performance Anxiety (Situational Use)

Propranolol is the preferred beta-blocker for acute performance anxiety, such as public speaking or test-taking anxiety. 1

  • Dosing: Take 20-40 mg of propranolol 1 hour before the anxiety-provoking event 1
  • Mechanism: Blocks peripheral adrenaline effects, reducing rapid heart rate, tremors, and nervousness without sedation 1, 3
  • Important: Patients should trial the dose before an important event to assess individual response and tolerability 1
  • Combination approach: Can be combined with cognitive behavioral therapy (CBT) and relaxation techniques for optimal results 1

Chronic Anxiety Disorders

For generalized anxiety disorder, panic disorder, and chronic social anxiety disorder, SSRIs and SNRIs are first-line pharmacotherapy, NOT beta-blockers. 1, 2

  • Canadian Clinical Practice Guidelines and Japanese guidelines explicitly recommend against propranolol for chronic social anxiety disorder due to negative evidence 1, 2
  • A 2025 systematic review and meta-analysis found no evidence for beneficial effects of beta-blockers compared with placebo or benzodiazepines in patients with social phobia or panic disorder 4
  • If frequent or chronic performance anxiety requires treatment, use CBT as first-line, and if pharmacotherapy is needed chronically, prescribe SSRIs/SNRIs, not beta-blockers 1

When Beta-Blockers May Have Limited Role

Beta-blockers may provide symptomatic relief in anxiety presentations with prominent physical symptoms (cardiovascular manifestations like palpitations, tremor), but this is not their primary indication. 3, 5

  • α-2 agonists (clonidine, guanfacine) are sometimes used for anxiety management, though evidence in this population is limited 6
  • Benzodiazepines are not recommended for chronic anxiety due to dependence risk and behavioral side effects 6

Critical Contraindications and Precautions

Screen carefully before prescribing beta-blockers for anxiety:

  • Absolute contraindications: Asthma, COPD, bradycardia, heart block, decompensated heart failure 1, 3
  • Diabetes: May mask hypoglycemia symptoms (tachycardia); use with extreme caution 6, 1, 3
  • Common side effects: Bradycardia, hypotension, fatigue, cold extremities, sleep disturbances 1
  • Never abruptly discontinue after regular use due to rebound symptoms 1, 3

Propranolol vs. Metoprolol

  • Propranolol (non-selective beta-blocker) is the established agent for performance anxiety with up to 70% effectiveness for essential tremor 1
  • Metoprolol (beta-1 selective) has fewer respiratory side effects but is less effective and considered second-line 3
  • Metoprolol may be preferred in patients with mild respiratory concerns, but propranolol remains the standard 3

Clinical Algorithm for Anxiety Treatment

For isolated, infrequent performance anxiety:

  1. Screen for contraindications (asthma, COPD, heart block, bradycardia, heart failure)
  2. Prescribe propranolol 20-40 mg to take 1 hour before event
  3. Advise trial dose before important event
  4. Consider CBT as adjunct 1

For chronic or frequent anxiety:

  1. First-line: CBT alone or with SSRIs/SNRIs
  2. Do NOT use beta-blockers chronically
  3. Reserve propranolol only for specific situational events within a chronic anxiety disorder 1, 2

Evidence Quality Note

While older studies from the 1970s-1990s suggested benefit for chronic anxiety 7, 5, 8, 9, the most recent 2025 systematic review and meta-analysis found insufficient evidence to support beta-blocker use for chronic anxiety disorders 4. Current guidelines from 2020-2025 consistently recommend against beta-blockers as first-line treatment for chronic anxiety, reserving them exclusively for situational performance anxiety. 1, 2

References

Guideline

Propranolol for Stage Fright

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol for Anxiety: Efficacy and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoprolol for Anxiety Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The treatment of anxiety with beta-blocking drugs.

Postgraduate medical journal, 1988

Research

Propranolol in the treatment of anxiety.

Postgraduate medical journal, 1976

Research

Propranolol in chronic anxiety disorders. A controlled study.

Archives of general psychiatry, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.